Keybanc Initiates Coverage On Lumexa Imaging Hldgs with Overweight Rating, Announces Price Target of $18

Keybanc analyst Matthew Gillmor has initiated coverage on Lumexa Imaging Holdings (NASDAQ: LMRI) with an Overweight rating. The firm has set a price target of $18 for the company's stock.